RESULTS OF STENTING OF SUPERFICIAL FEMORAL ARTERY ATHEROSCLEROTIC LESIONS
https://doi.org/10.21886/2219-8075-2014-4-104-109
Abstract
Purpose: to estimate the primary patency rate and clinical improvement in patients with atherosclerotic lesions of superficial femoral artery (SFA) after it’s angioplasty and stenting.
Materials and methods: 114 patients in an age of 40-86 yo with occlusive-stenotic lesions of the SFA were operated on using endovascular angioplasty with stenting. All patients were evaluated clinically and using duplex ultrasound; in some cases CT-scanning and angiography were also selected.
Results: at the 30-months follow-up period were estimated. Acute technical success was achieved in all patients. Restenosis occurred in 15 (13,1%) and reocclusion in 9 (7,9%) lesions at 6 months. At 30 months restenosis was revealed in 24 (21%) and reocclusion in 25 (21,9%). These complications demand restenting in 5 (4,4%) with restenosis, in 8 (7,1%) - femoropopliteal open bypass and in 12 (10,5%) - amputation.
Summary: the primary patency of SFA after 30-months follow-up period was revealed in 57,1% patients.
Materials and methods: 114 patients in an age of 40-86 yo with occlusive-stenotic lesions of the SFA were operated on using endovascular angioplasty with stenting. All patients were evaluated clinically and using duplex ultrasound; in some cases CT-scanning and angiography were also selected.
Results: at the 30-months follow-up period were estimated. Acute technical success was achieved in all patients. Restenosis occurred in 15 (13,1%) and reocclusion in 9 (7,9%) lesions at 6 months. At 30 months restenosis was revealed in 24 (21%) and reocclusion in 25 (21,9%). These complications demand restenting in 5 (4,4%) with restenosis, in 8 (7,1%) - femoropopliteal open bypass and in 12 (10,5%) - amputation.
Summary: the primary patency of SFA after 30-months follow-up period was revealed in 57,1% patients.
About the Author
S. B. Tursunov
Pirogov Russian National Research Medical University
Russian Federation
Department of Surgical Diseases
Russian Federation
Department of Surgical Diseases
References
1. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., TASC II Working Group: Inter-society consensus for the management of peripheral arterial disease (TASC II)// J Vasc Surg. - 2007. - V.45(Suppl S). - P. 5-67.
2. Setacci C., de Donato G., Teraa M., Moll F.L., Ricco J.B., Becker F., et al: Chapter IV: treatment of critical limb ischaemia [Review]. EurJVascEndovascSurg – 2011. - 42(Suppl 2): P.43-59.
3. Российский консенсус. / Рекомендуемые стандарты для оценки результатов лечения пациентов с хронической ишемией нижних конечностей. – Казань, 2001.
4. Клиническая ангиология: в 2-х томах. / Под ред. ак. А.В. Покровского - М.: 2004; 69c. – 1 т.
5. Национальные рекомендации по ведению больных с заболеваниями артерий нижних конечностей. - М., 2013. – 70 с.
6. Johnston K.W. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. // Radiology. - 1992. - Р. 767–771.
7. Buechel R., Stignimann A., Zimmer R. e.a. Drug-eluting stents and drug-coated balloons in peripheral artery disease. // Vasa. – 2012. - №41. - P. 248-261.
8. Scott N.A., Cipolla G.D., Ross C.E. e.a. Identification of a Potential Role for the Adventitia in Vascular Lesion Formation After Balloon Overstretch Injury of Porcine Coronary Arteries. // Circulation. – 996. -№93(12). – Р. 2178 – 2187.
9. Laird J.R., Katzen B.T., Scheinert D. et al., Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery:twelve-month results from the RESILIENT randomized trial. // CircCardiovascInterv. – 2010. – №3. – Р. 267–276.
10. Krankenberg H, Schlüter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST). // Circulation. – 2007. – Р. 116:285–92.
11. Dake M, Ansel G, Jaff M, et al. Zilver PTX: a prospective, randomized trial of the polymer-free paclitaxel-eluting stent compared to balloon angioplasty with provisional bare metal stenting in patients with superficial femoral artery disease (abstr). Paper presented at: Twenty-Second Annual Transcatheter Cardiovascular Therapeutics Symposium; September 21–25; Washington, DC. J Am CollCardiol 2010;56:xiii.
12. Dick P., Wallner H., Sabeti S., Loewe C., Mlekusch W., Lammer J., Koppensteiner R., Minar E., Schillinger M: Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. // Catheter CardiovascInterv. – 2009. – Р. 74:1090–1095.
13. Schillinger M., Sabeti S., Dick P., Amighi J., Mlekusch W., Schlager O., Loewe C., Cejna M, Lammer J, Minar E: Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. // Circulation. – 200. – Р. 115:2745–2749.
Review
For citations:
Tursunov S.B. RESULTS OF STENTING OF SUPERFICIAL FEMORAL ARTERY ATHEROSCLEROTIC LESIONS. Medical Herald of the South of Russia. 2014;(4):104-109. (In Russ.) https://doi.org/10.21886/2219-8075-2014-4-104-109
Views:
490
Email this article 